Together, these experiments validate RNP nucleofection of resting human CD4+ T cells as a rapid and effective method for gene editing, depletion of specific cellular factors and subsequent functional characterization in the context of HIV-1 infection in these thus far experimentally inaccessible primary human target cells. The gene discussed is CD4; the disease is HIV-1 infection.